Impact of anti-proliferative drugs and mesh size of active stents on recanalized CTOs at 1 year

  • Project's holder

    Dr Julien ADJEDJ

  • Promoter

    Association France PCI

  • Contact


  • Funding

    Non

  • Sample data used

    From 05/01/2014 to 05/01/2022

  • Project progress

    In progress

Project summary

CONTEXT

Total coronary occlusion (CTO) recanalizations represent a major advance in the field of complex angioplasty. The long-term results of these recanalizations are uncertain and require systematic monitoring after 1 year.


GOALS

To evaluate the impact of different antiproliferative drugs on long-term outcomes of recanalization success.

To evaluate the impact of active stent mesh size on long-term outcomes of recanalized CTOs.


METHODOLOGY

Inclusion of any recanalized CTO without residual stenosis with active stent implantation.


Information patients